Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Oncormed Collaborate to Develop Expression Database


SANTA CLARA--Affymetrix and Oncormed announced they will codevelop a gene expression database as a tool to enable the use of gene expression data in drug development by third party subscribers. The new agreement further leverages Oncormed's strength in gene characterization and pharmacogenomics with Affymetrix's GeneChip expression analysis tools. The collaboration is the third in a series of agreements between the companies, representing a relationship that began with the development and validation of a GeneChip assay for identifying mutations in the p53 gene.

Under the new agreement, Oncormed and Affymetrix will work together to build a high resolution gene expression database. The initial phase will focus on profiling selected genes against tissues from more than a dozen normal and diseased organ systems believed to be highly relevant to the drug development process. Affymetrix will design and supply custom and standard expression monitoring GeneChip probe arrays and related technology to facilitate the analysis of tissue samples. Oncormed will contribute tissue samples and apply its expertise in tissue pathology and molecular genetics to generate high-resolution gene expression data using GeneChip technology. Together the two companies will build the gene expression database.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.